49
Introduction 7 showed dense intermingling and multiple foci of close apposition with NK3R containing cells and 149 fibers, but no co-expression within GnRH cell bodies (>100 cells analyzed from a total of 16 mice; 150 Figure 3C ). Interestingly, we observed no fibers containing NK3R immunoreactivity in the internal 151 or external zone of the median eminence (ME; Figure 3A, 3B) . 152
To identify the brain area in which NK3R receptive neurons that mediate the kisspeptin-153 independent GnRH release reside, we stereotaxically administered senktide specifically into the 154 ARC, the POA (at the level of the MS) or the MeA. These areas are prime candidates to play a 155 role in LH stimulation because (a) they contain NK3R, the immunoreactivity of which is regulated 156 by E2, (b) there is an anatomical overlap of NK3R and GnRH protein, at least in the MS and ARC 157 and (c) they contain GnRH and/or Kiss1 cell bodies and fibers and are known to play an important 158 role in reproductive function (Smith et al., 2006 , Kim et al., 2011 . Senktide administration into the 159 ARC or POA of WTOVX+E2 mice stimulated LH secretion within 15 min from drug infusion ( Figure  160 3D, 3E; P<0.0001 for both) compared to Kiss1 KO animals. However, when senktide was 161 administered into the MeA of WTOVX+E2 and Kiss1 KO females supplemented with E2 a robust 162 increase in LH was observed within 15 min after senktide infusion that was similar in both 163 genotypes ( Figure 4D) . Conversely, in the absence of E2, Kiss1 KO females did not show any 164 alteration in LH release ( Figure 4D) , mimicking the LH responses we obtained after an ICV 165 injection of senktide in these animals ( Figure 1B) . 166
Chemogenetic activation of the MeA Kiss1 neuron stimulates LH release in WT but not 167
Kiss1 KO female mice. 168 Similar to the experiments described above, we delivered Cre-dependent AAV5-DIO-169 hM3Dq:mCherry to the MeA of Kiss1 Cre/+ or Kiss1 Cre/Cre mice. HM3Dq:mCherry expression was 170 present in the MeA (Figure 4F) and was limited to sections ranging from (from -1.6 mm to -2.0 171 mm from bregma; paxinos atlas). Two out of eight mice (one from each group) had primarily 172 unilateral spread of the DREADD, but they did not differ significantly from their respective groups 173 in LH concentrations, and were therefore, included in further analyses. Within the MeA, mCherry 174 cell bodies were co-expressed in ~89 % of GFP-immunoreactive cells (i.e. Kiss1 cells), and was 175 not observed in non-GFP cells. 176 Kiss1 Cre/+ mice expressing hM3Dq:mCherry in the MeA and treated with CNO to activate 177 the Kiss1 MeA neurons, had an increase in LH within 30 min after the injection (P=0.0107) compared 178 to animals receiving saline treatment, which was sustained for another 30 min before returning to 179 basal levels ( Figure 4G) . No alteration in LH was observed in E2-supplemented Kiss1 KO animals 180 treated with either saline or CNO ( Figure 4H) . 181
Discussion

182
Our results provide evidence that the MeA is a component of the gonadotropin axis. 183
Specifically, we have identified two independent pathways within the MeA that can lead to the 184 stimulation of GnRH/LH release. The first involves Kiss1 MeA neurons, the activation of which, 185 stimulates LH release into the peripheral circulation. Furthermore, this is achieved by the release 186 of kisspeptin and not by any other signaling molecules produced within the Kiss1 MeA neuron, since 187 LH was increased only in animals with an intact kisspeptin signaling system. A second pathway, 188 involving NKB/NK3R signaling, was also identified, when senktide (NK3R agonist) administration 189 into the MeA induced LH release in Kiss1 KO mice (Padilla et al., 2018) . Thus, kisspeptin is not 190 a required mediator between NK3R activation in the MeA and LH secretion. Interestingly, this 191 pathway is female-specific and estrogen-dependent as responses were absent in males and 192 hypogonadal females. 193
From a mechanistic point of view, the most likely kisspeptin-independent pathway for LH 194 stimulation by NKB would involve the direct regulation of GnRH release (Krajewski et al., 2005) . 195
Despite there being an anatomical overlap of GnRH and NK3R protein, specifically in the ARC 196 and POA (at the level of the MS), we observed no instances of colocalization between NK3R 9 and GnRH cell bodies irrespective of the presence or absence of sex steroids. This reveals 198 certain anatomical differences to what has been previously demonstrated in the rat, where 199 ~16% of GnRH cell bodies were found to contain NK3R protein (Krajewski et al., 2005) . 200
However, our results agree with reports of no NK3R expression in GnRH neurons of the ewe 201 (Amstalden et al., 2010) suggesting the existence of species differences. Overall, our data 202 suggest that the kisspeptin-independent action of NKB cannot be attributed to direct stimulation 203 of NK3R located on GnRH neurons. 204
Kiss1 ARC (KNDy) neurons make close appositions with GnRH cell bodies and terminals 205 and may therefore stimulate GnRH neurons through intermediates other 206 than kisspeptin. For example, it has been demonstrated with in vitro examination of coronal brain 207 slices, that senktide induces GnRH release from the ME and this effect is, in part, present in Kiss1 208 KO mice (Gaskins et al., 2013) . We did not observe any NK3R immunoreactive fibers in the 209 internal or external zone of the median eminence, indicating a potential lack of direct NKB (or 210 senktide) regulation of the GnRH terminals in that area. Nonetheless, other signaling molecules 211 such as glutamate (Nestor et al., 2016) or galanin, γ-aminobutiric acid (Skrapits et al., 2015) can 212 potentially stimulate LH secretion and must also be considered. However, activation of the 213 Kiss1 ARC (KNDy) neuron stimulated LH release only in mice with an intact kisspeptin signaling 214 system and was completely absent in Kiss1 KO mice. This provides evidence that kisspeptin, but 215 no other signaling molecule produced by Kiss1 ARC (KNDy) neuron can stimulate LH release in 216
vivo. 217
The distribution of NK3R has been described in the human, rat, and ewe (Mileusnic et al., 218 1999 , Krajewski et al., 2005 , Amstalden et al., 2010 and here, we confirm a similar distribution in 219 the mouse brain. Interestingly, in certain areas the immunoreactivity of NK3R-containing cell 220 bodies was highly dependent on sex steroid levels. Specifically, estrogen downregulated NK3R 221 expression in the ARC whereas the opposite was true for the MeA, with more NK3R containing 222 cell bodies evident when animals were supplemented with E2. High sensitivity of NK3R expression 223 to E2, has also been reported for the ARC with in situ hybridization studies (Navarro et al., 2009) . 224
Interestingly, this regulation of NK3R expression is reminiscent of the regulation of Kiss1 by E2 in 225 these areas (Kim et al., 2011 , Smith et al., 2006 . 226
Based on the aforementioned anatomical observations we proceeded with senktide 227 administration into the ARC, POA (at the level of the MS) and MeA of E2-treated animals in order 228 to locate the kisspeptin-independent, LH-stimulating population of NK3R-expressing neurons. 229
Senktide administration into the ARC or POA (at the level of the MS) significantly stimulated LH 230 secretion in WT females compared to Kiss1 KO animals. Therefore, our data suggest that LH 231 release, as a result of NKB/NK3R signaling in the POA or ARC, is predominantly achieved via 232 initial kisspeptin release, involving Kiss1 AVPV/PeN and/or Kiss1 ARC neuron activation. Indeed, 10% 233 of Kiss1 AVPV/PeN and virtually all Kiss1 ARC neurons contain NK3R (Navarro et al., 2015) . Moreover, 234 both populations are interconnected, Kiss1 ARC cells project to Kiss1 AVPV/PeN neurons and GnRH 235 cell bodies and terminals (Yip et al., 2015) , which could also account for the increase in LH after 236 administration of senktide into the POA. However, a slight increase in LH occurred in the absence 237 of kisspeptin signaling (Kiss1 KO mice). In the ARC and MS of the POA, we observed several 238 instances were NK3R containing fibers were in close apposition to GnRH cell bodies and/or 239 processes indicating a potential presynaptic action of NKB onto GnRH. It is possible that NKB (or 240 senktide) signaling onto presynaptic NK3R, results in the enhanced secretion of other stimulatory 241 neuropeptides, which in turn stimulate GnRH secretion and could account for the slight increase 242 in LH observed in Kiss1 KO mice, as recently documented in the rat striatum, in which tachykinins 243 (including NKB) presynaptically stimulate the release of dopamine (Glowinski et al., 1993) . 244
Interestingly, senktide administration into the MeA of females supplemented with E2 245 produced a similar robust increase in LH in animals with or without the presence of the Kiss1 246 gene. Conversely, hypogonadal Kiss1 KO females did not show any alteration in LH release, 247
indicating that this kisspeptin-independent NKB/NK3R signaling mechanism in the MeA becomes 248 activated only when E2 is present. This notion is further supported by our finding that the number 249 of NK3R cells increases with E2, and this upregulation is specific to the MeA. NK3R MeA expressing 250 cells do not co-localize with NKB, but are surrounded by a plethora of NKB fibers (Supplemental 251 To investigate the mechanism further, we determined whether this is mediated directly or 256 indirectly by Kiss1 MeA neurons through the release of kisspeptin or other signaling molecules. it is compelling to hypothesize that the kisspeptin-independent, NK3R-dependent pathway is 275 employed for the generation and/or enhancement of the LH surge and/or female sexual behavior, 276 e.g. lordosis, given that this mechanism was absent in male mice, and is exclusively activated in 277 the presence of estrogen, similar to what is observed in the female AVPV/PeN (Smith et al., 2006) . 278
In accordance, recent evidence demonstrated the enhancement of the LH surge in rats exposed 279 In summary, we have shown that the MeA is a previously unknown component of the 283 gonadotropic axis. Initially, we observed that senktide administration into the lateral ventricle 284 stimulates LH release into the peripheral circulation of female mice lacking kisspeptin (Kiss1 KO), 285 but only when they are supplemented with E2. Upon further investigation, we identified two 286 mechanisms that can lead to GnRH/LH secretion in the female, involving Kiss1 MeA or NK3R-287 expressing neurons located in the MeA. Collectively, these data demonstrate that the 288 gonadotropic axis is subject to regulation by signalling originating outside the hypothalamus and 289 specifically the MeA, involved in the regulation of social behaviors including sexual behavior, 290 anxiety, and olfaction. 291
Methods
293
Animals 294 A Kiss1 Cre:GFP knock-in mouse (version 2) was generated from C57Bl/6 blastocysts and 295 Rodent Diet 8664) and were given ad libitum access to tap water. For all studies, C57Bl/6 WT or 301 Kiss1 Cre/+ (heterozygous state) males or females between age 8 and 20 weeks were used and 302 studied in parallel to Kiss1 Cre/Cre (Kiss 1 knock-out state) littermates. In order to test the specificity 303 of the NK3R antibody, NK3RKO mice were used as described below. 304
Experiment 1: Effect of central (ICV) administration of senktide on LH release in male and 305 female WT and Kiss1 KO mice with or without the presence of sex steroids. 306
In this experiment we aimed to assess whether central activation of ΝΚ3R signaling with 307 senktide (an NK3R specific agonist), can stimulate LH release in Kiss1 KO mice (i.e., in a 308 kisspeptin-independent manner) in the presence or absence of sex steroids. Adult WT male and 309 female mice were GND and studied in parallel to hypogonadal (with low sex steroid levels) Kiss1 310 KO littermates (n=10/group). ICV injections (see below) of senktide (Tocris Biosience, Cat. No. 311 1068; 600 pmol diluted in 5µl 0.9% NaCl) were performed and blood samples were collected 312 before (basal) and 25 min after ICV injection for LH measurements as has been previously 313 described (Navarro et al., 2015) . Next, animals were implanted with sex steroids (n=10/group) 314 and the ICV experiment was repeated a week later. The dose of senktide used, and the time of 315 blood collection were selected based on our previous studies (Navarro et al., 2015) . 316
Experiment 2: Effect of ARC KNDy neuron chemogenetic activation on LH release in WT 317 and Kiss1 KO female mice in the presence of estradiol. 318
In order to determine whether the release of other components, besides kisspeptin, within 319 the Kiss1 ARC (KNDy) neuron can stimulate LH release, we used a chemogenetic approach to 320 specifically activate Kiss1 ARC neurons of Kiss1 Cre/+ or Kiss1 Cre/Cre mice treated with E2 (n=5-321 8/group). Females received bilateral stereotaxic injections (see below) of an adeno-associated 322 virus (pAAV) encoding a Cre-driven Gq-coupled DREADD (pAAV5/hSyn-DIO-hm3Dq:mCherry; 323 Addgene, Cat. No.44361-AAV5; titer 3x10 12 genome copies per ml; 1 µl per hemisphere). 324
Following infection, mice were given 3 weeks for recovery and maximum expression of the AAV 325 vector. On the day 1 of the experiment animals were administered an ip bolus injection of vehicle 326 saline (0.9% NaCl; day 1) and then hM3D receptors were activated by ip injection of its agonist, 327 clozapine N-oxide (CNO; 10 mg/kg dissolved in saline; day 2). Blood samples were collected just 328 before saline or CNO treatment (0) and then every 15 min for 90 min. The dose of CNO was 329 chosen based on previous behavioral studies using hM3Dq manipulations (Ben-Shaanan et al., 330 2016). At the end of the experiment, all mice were treated with an icv injection of senktide, as a 331 control, and to confirm that animals were appropriately treated and primed. 332
Experiment 3: Effect of senktide administration in to the ARC, POA or MeA on LH release 333 in female WT and Kiss1 KO mice with the presence of estrogen. 334
In this set of experiments, we aimed to locate the brain area which senktide is acting to 335 stimulate LH release. To this end, we first conducted neuroanatomical studies to confirm NK3R 336 protein expression in the mouse hypothalamus, as well as to investigate the potential anatomical 337 interplay between NK3R and GnRH neurons, as the most plausible kisspeptin-independent 338 mechanism. Thus, WTOVX, WTOVX+E2, Kiss1 KO and Kiss1 KO+E2 (n=5/group) were perfused 339 following standard protocols and the brains were collected for immunohistochemical (IHC) 340 analyses, as described in detail below. Based on IHC results, a stereotaxic injection approach 341 was used to specifically activate NK3R in the POA (at the level of the MS), or ARC or MeA and 342 monitor LH responses in the peripheral circulation of anesthetized WTOVX+E2 and Kiss1 KO+E2 343 females. Unilateral injections were performed as described below on WTOVX+E2, and Kiss1 KO+E2 344 
Kiss1 KO GnRH priming 372
To exclude the possibility that absence in gonadotropin responses to the various stimuli in 373 hypogonadal Kiss1 KO mice may result from inadequate pituitary responsiveness to GnRH, which 374 has been previously described in animals with a defective Kiss1 signaling system (Roa et al., 375 2008) Kiss1 KO mice were subjected to a protocol of GnRH priming during 2 days prior testing, 376 as has been previously described (Garcia-Galiano et al., 2012). In this protocol, each mouse 377 received five successive ip boluses of a low dose of GnRH (0.15 µg/each), with the following 378 schedule: at 10:00 h, 17:00 h, and 23:50 h on the first day; at 0800 and 1600 on the second day 379 with neuroendocrine tests being conducted on the third day (Garcia-Galiano et al., 2012). WT 380 mice injected with saline vehicle, following the same protocol, served as controls. 381
Intracerebroventricular (ICV) Injections 382
ICV injections were performed following preciously published procedures (Navarro et al., 383 2015) . Briefly, 2-3 days before the experiment, mice were anesthetized with isoflurane and a small 384 hole was bored in the skull 1 mm lateral and 0.5 mm posterior to bregma with a Hamilton syringe 385 attached to a 27-gauge needle fitted with polyethylene tubing, leaving 2.0 mm of the needle tip 386 exposed. Once the initial hole was made, all subsequent injections were made at the same site. 387
On the day of ICV injection experiments, mice were anesthetized with isoflurane for a total of 5-388 10 min, during which time 5 μl of solution were slowly and continuously injected into the lateral 389 ventricle. The needle remained inserted for approximately 30 sec after the injection to minimize 390 backflow up the needle track. Mice typically recovered from the anesthesia within 3 min after the 391 injection. 392
Stereotaxic injections 393
Mice were deeply anaesthetized with isoflurane and placed into a stereotaxic apparatus 394 (Kopf Instruments, Model 940). After exposing the skull via incision, a small hole was drilled for 395 injection at the appropriate AP and ML coordinates. A syringe (Hamilton, 5 µL, Model 175 RN 396 SYR, 32 ga, Cat. No.80016) was lowered into the brain at the appropriate DV coordinates. 397
Coordinates relative to bregma were as follows: anteroposterior (AP) -1.6 mm, mediolateral (ML) 398 ± 0.25 mm and dorsoventral (DV) -5.85 mm for the ARC, AP +0.6 mm, ML ± 0.25 mm, DV -5.15 399 mm for the POA and AP -1.9 mm, ML ± 2.0 mm, DV -4.9 mm for the MeA. Injection sites were 400 chosen based on the Paxinos Brain Atlas, and confirmed with India Ink (Fisher Scientific, Cat. No. 401 NC9903975) trial injections. Each infusion was slowly delivered over 2 min (500 nl/min), the 402 needle was left in place for an additional 5 min (for AAV injections) and 15 min (for senktide 403 administrations) and then slowly withdrawn to minimize backflow. Animals received 0.3 mg/kg 404 buprunex (subcutaneous) during surgery and 24 h later for analgesia and were allowed a 3-week 405 recovery before onset of experiments. 406
Blood Samples and LH measurements 407
In all cases blood samples for LH measurements were obtained after a single excision of 408 the tip of the tail. The tip was cleaned with saline and then massaged prior to taking a 4 µl blood 409 sample from the tail tip with a pipette. Whole blood was immediately diluted in 116 µl of 0.05% 
Microscopy and image analysis 480
Validation of senktide injection site. 481
The locations of POA, ARC and MeA injection sites were investigated in sections cut at 482 20 μm thickness using a cryostat (Fisher, HM505E). Every other section was collected around 483 the injection site, mounted on microscope slides air-dried and cover slipped with Vectashield 484
HardSet Mounting Medium (Vector Laboratories, Burlingame, CA). Only animals with accurate 485 and restricted injection sites were included in the analysis. 486
Validation of chemogenetic activation of ARC KNDy or MeA Kiss1 neurons. 487
Sections from animals injected with AAV vectors encoding hM3Dq:mCherry in the ARC or 488
MeA were examined, and the location of mCherry expression was confirmed in GFP positive 489 neurons. In both cases, quantification of GFP and GFP/mCherry positive neurons in all areas was 490 carried out in a subpopulation of animals (n=4/group) with images taken at x20 magnification from 491 2 representative sections per animal. 492
NK3R/GnRH anatomical relationship 493
The anatomical relationship between NK3R/GnRH (throughout the hypothalamus), 
Quantitative real-time RT PCR 3
We aimed to confirm the lack of Kiss1 expression in the POA and MBH of Kiss1 KO mice. WT 4 (OVX; n=3) and Kiss1 KO (n=5) female mice were killed, brains were exposed and the POA 5 and MBH was extracted and immediately frozen in dry ice and stored at −80 C. Total RNA 6 from both areas was isolated using TRIzol reagent (Invitrogen) followed by 7 chloroform/isopropanol extraction. RNA was quantified using NanoDrop 2000 8 spectrophotometer (Thermo Scientific) and one microgram of RNA was reverse transcribed 9
using Superscript III cDNA synthesis kit (Invitrogen). Quantitative real-time PCR assays were 10 performed in triplicates of each sample on an ABI Prism 7000 sequence detection system, 11
and analyzed using ABI Prism 7000 SDS software (Applied Biosystems). The cycling 12 conditions were as follows: 2 min incubation at 50°C, 10 min incubation at 95°C (hot start), 40 13 amplification cycles (95°C for 15 s, 60°C for 1 min, and 45 s at 75°C, with fluorescence 14 detection at the end of cycles 3 -40), followed by melting curve of the amplified products 15 obtained by ramped increase of the temperature from 55 to 95°C to confirm the presence of 16 single amplification product per reaction. The primers used are listed in Table 1 . The data 17
were normalized using L19 primers as an internal control. Kiss1 expression was detected 18 using primers: F-CTCTGTGTCGCCACCTATGC R -TTCCCAGGCATTAACGAGTTC. 19
Values were normalized with housekeeping gene Rpl19. 20
Immunohistochemistry for mCherry and GnRH 21
mCherry and GnRH. Brains from Kiss1 Cre/+ and Kiss1 Cre/Cre mice (n=5/group) injected with 22 AAV5-hSyn-DIO-hM3D(Gq)-mCherry were assessed for mCherry reporter expression and 23
GnRH to confirm anatomical integrity of Kiss1 neuron and GnRH fiber interaction in the area. 
